{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:06Z","timestamp":1786986846461,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clineuro.2026.109467","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:06:45Z","timestamp":1777964805000},"page":"109467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Feasibility and usefulness of personalised patient-reported outcome measures in the therapeutic follow-up of adult spinal muscular atrophy patients"],"prefix":"10.1016","volume":"267","author":[{"given":"Pascal","family":"Cintas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pouplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Deberg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-7798","authenticated-orcid":false,"given":"Vincent","family":"Fabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Acket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Letelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Pigeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Masurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Caire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clineuro.2026.109467_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2026.109467_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D'Amico","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109467_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel","year":"2014","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.clineuro.2026.109467_bib4","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1212\/WNL.0000000000009248","article-title":"Population-based analysis of survival in spinal muscular atrophy","volume":"94","author":"Wijngaarde","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2026.109467_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.clineuro.2026.109467_bib6","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s12325-025-03260-1","article-title":"Systematic review and meta-analysis of long-term nusinersen effectiveness in adolescents and adults with spinal muscular atrophy","volume":"42","author":"Hagenacker","year":"2025","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109467_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s13311-022-01200-3","article-title":"Nusinersen in adults with 5q spinal muscular atrophy: a systematic review and meta-analysis","volume":"19","author":"Gavriilaki","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109467_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00415-025-13557-4","article-title":"Safety and effectiveness of risdiplam in adults with spinal muscular atrophy: a systematic review","volume":"273","author":"Alonge","year":"2025","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109467_bib9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mus.28327","article-title":"Risdiplam in Adult Patients With 5q Spinal Muscular Atrophy: A Single-Center Longitudinal Study","volume":"71","author":"Gavriilaki","year":"2025","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109467_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"12","key":"10.1016\/j.clineuro.2026.109467_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the expanded hammersmith functional motor scale in spinal muscular atrophy type II and III","volume":"26","author":"Glanzman","year":"2011","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109467_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.25430","article-title":"Revised upper limb module for spinal muscular atrophy: development of a new module","volume":"55","author":"Mazzone","year":"2017","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109467_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JND-230001","article-title":"Psychometric characteristics of the motor function measure in neuromuscular diseases: a systematic review1","volume":"10","author":"Ribault","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"issue":"12","key":"10.1016\/j.clineuro.2026.109467_bib14","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1111\/ene.15542","article-title":"Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy","volume":"29","author":"Vazquez-Costa","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2026.109467_bib15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00415-020-09847-8","article-title":"Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy","volume":"267","author":"Osmanovic","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2026.109467_bib16","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.2147\/IJGM.S369021","article-title":"Experience and perspectives in the us on the evolving treatment landscape in spinal muscular atrophy","volume":"15","author":"Ramos-Platt","year":"2022","journal-title":"Int J. Gen. Med"},{"issue":"11","key":"10.1016\/j.clineuro.2026.109467_bib17","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/ene.15501","article-title":"Nusinersen in adult patients with 5q spinal muscular atrophy: a multicenter observational cohorts' study","volume":"29","author":"Vazquez-Costa","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109467_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/22143602251336076","article-title":"Thinking outside the box: A re-evaluation of Canadian recommended outcome measures in adult spinal muscular atrophy - report of a national consensus workshop","volume":"12","author":"O'Connell","year":"2025","journal-title":"Neuromuscul. Dis."},{"key":"10.1016\/j.clineuro.2026.109467_bib19","unstructured":"ICER Final Evidence Report on Therapies for Spinal Muscular Atrophy t \u3008https:\/\/icer.org\/wp-content\/uploads\/2025\/08\/ICER_SMA_Final-Report_For-Publication_090225-1.pdf\u3009."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109467_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/000841748705400308","article-title":"Measurement in Occupational Therapy: Scientific Criteria for Evaluation","volume":"54","author":"Law","year":"1987","journal-title":"Can. J. Occup. Ther."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109467_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/000841740407100406","article-title":"The Canadian Occupational Performance Measure: a research and clinical literature review","volume":"71","author":"Carswell","year":"2004","journal-title":"Can. J. Occup. Ther."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109467_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1682\/JRRD.2010.06.0110","article-title":"Responsiveness of the Canadian occupational performance measure","volume":"48","author":"Eyssen","year":"2011","journal-title":"J. Rehabil. Res Dev."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109467_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/NRE-230219","article-title":"Changes in self-perceived performance and satisfaction with performance of daily activities following interdisciplinary rehabilitation in people with late effects of polio","volume":"54","author":"Appelin","year":"2024","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.clineuro.2026.109467_bib24","series-title":"Goal attainment scaling. 1st edition ed","author":"Kiresuk","year":"1994"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109467_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12883-021-02166-z","article-title":"Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers' perspective: a two-part study","volume":"21","author":"Duong","year":"2021","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109467_bib26","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00415-023-11560-1","article-title":"SUNFISH Working Group.Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)","volume":"270","author":"Oskoui","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2026.109467_bib27","article-title":"A Patient-Centered Evaluation of Meaningful Change on the 32-Item Motor Function Measure in Spinal Muscular Atrophy Using Qualitative and Quantitative Data","volume":"12","author":"Duong","year":"2021","journal-title":"Front Neurol."},{"issue":"18","key":"10.1016\/j.clineuro.2026.109467_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191811321","article-title":"20 Years of ICF-International Classification of Functioning, Disability and Health: Uses and Applications around the World","volume":"19","author":"Leonardi","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"issue":"9","key":"10.1016\/j.clineuro.2026.109467_bib29","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s12325-025-03260-1","article-title":"Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy","volume":"42","author":"Hagenacker","year":"2025","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109467_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00415-025-13557-4","article-title":"Safety and effectiveness of risdiplam in adults with spinal muscular atrophy: a systematic review","volume":"273","author":"Alonge","year":"2025","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109467_bib31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neurol.2021.10.010","article-title":"Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study","volume":"178","author":"Lefeuvre","year":"2022","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109467_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13023-023-02769-4","article-title":"Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience","volume":"18","author":"Lusakowska","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109467_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JND-221595","article-title":"Patient reported outcome measures in adult spinal muscular atrophy: a scoping review and graphical visualization of the evidence","volume":"10","author":"Slayter","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109467_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12311-025-01932-w","article-title":"The Goal attainment scale in spinocerebellar ataxia type 3: exploration of feasibility and content validity","volume":"24","author":"Leeuwenberg","year":"2025","journal-title":"Cerebellum"},{"key":"10.1016\/j.clineuro.2026.109467_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120059","article-title":"Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA","volume":"432","author":"Trundell","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2026.109467_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.apmr.2015.08.424","article-title":"Proposed criteria for appraising goal attainment scales used as outcome measures in rehabilitation research","volume":"97","author":"Krasny-Pacini","year":"2016","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.clineuro.2026.109467_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9963030","article-title":"Canadian occupational performance measure: benefits and limitations highlighted using the delphi method and principal component analysis","volume":"2022","author":"Caire","year":"2022","journal-title":"Occup. Ther. Int"},{"issue":"8","key":"10.1016\/j.clineuro.2026.109467_bib38","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1191\/0269215505cr883oa","article-title":"The reproducibility of the Canadian occupational performance measure","volume":"19","author":"Eyssen","year":"2005","journal-title":"Clin. Rehabil."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:30:41Z","timestamp":1782513041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S0303846726001599"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109467","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and usefulness of personalised patient-reported outcome measures in the therapeutic follow-up of adult spinal muscular atrophy patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109467"}}